SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Q. Xie, H. Zhou, X. Bai, S. Wu, J.-J. Chen, J. Sheng, Y. Xie, C. Chen, H. L.-Y. Chan, M. Zhao, A Randomized, Open-Label Clinical Study of Combined Pegylated Interferon Alfa-2a (40KD) and Entecavir Treatment for Hepatitis B "e" Antigen-Positive Chronic Hepatitis B, Clinical Infectious Diseases, 2014,

    CrossRef

  2. 2
    Ma Li-Na, Ding Xiang-Chun, Liu Xiao-Yan, Xu Chun-Qiong, Shuai-Wei Liu, Xie Yan, De novo combination therapy adefovir plus lamivudine as a treatment for women of child-bearing age with HBeAg-positive chronic hepatitis B Before Pregnancy, Journal of Medical Virology, 2014, 86, 3
  3. 3
    Jia-Feng Wu, Wen-Yu Tsai, Yi-Ching Tung, Huey-Ling Chen, Yen-Hsuan Ni, Hong-Yuan Hsu, Mei-Hwei Chang, Effect of Menarche Onset on the Clinical Course in Females with Chronic Hepatitis B Virus Infection, The Journal of Pediatrics, 2014, 165, 3, 534

    CrossRef

  4. You have free access to this content4
    JSH Guidelines for the Management of Hepatitis B Virus Infection, Hepatology Research, 2014, 44,
  5. 5
    Donatella Ieluzzi, Loredana Covolo, Francesco Donato, Giovanna Fattovich, Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy, Digestive and Liver Disease, 2014, 46, 5, 427

    CrossRef

  6. 6
    Jia-Feng Wu, Wen-Yu Tsai, Yi-Ching Tung, Huey-Ling Chen, Yen-Hsuan Ni, Hong-Yuan Hsu, Mei-Hwei Chang, Role of serum dehydroepiandrosterone sulfate level on the clearance of chronic hepatitis B virus infection, Journal of Gastroenterology, 2014, 49, 5, 900

    CrossRef

  7. 7
    Rosa María Martín-Mateos, Víctor F. Moreira Vicente, Luis Téllez-Villajos, Concepción García-Sánchez, María Teresa Maroto-Castellanos, Francisco Javier García-Alonso, María Luisa Mateos-Lindemann, Agustín Albillos, Tratamiento de la hepatitis crónica B antígeno e positiva con antivirales orales: experiencia y resultados en la práctica clínica, Gastroenterología y Hepatología, 2014, 37, 5, 280

    CrossRef

  8. 8
    Pierre Van Damme, John Ward, Daniel Shouval, Steven Wiersma, Alessandro Zanetti, Vaccines, 2013,

    CrossRef

  9. 9
    Alexander Kuo, Robert Gish, Chronic Hepatitis B Infection, Clinics in Liver Disease, 2012, 16, 2, 347

    CrossRef

  10. 10
    Ming-Jen Lin, Pei-Jer Chen, Ming-Ching Luoh, HBeAg(+) and sex ratio of offspring: Evidence form Taiwan's three million newborns, American Journal of Human Biology, 2012, 24, 4
  11. 11
    Sung Kwan Bae, Hiroshi Yatsuhashi, Satoru Hashimoto, Yasuhide Motoyoshi, Eisuke Ozawa, Shinya Nagaoka, Seigo Abiru, Atsumasa Komori, Kiyoshi Migita, Minoru Nakamura, Masahiro Ito, Yuzo Miyakawa, Hiromi Ishibashi, Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liver, Medical Science Monitor, 2012, 18, 12, CR698

    CrossRef

  12. 12
    Jia-Feng Wu, Yu-Ru Su, Chen-Hsin Chen, Huey-Ling Chen, Yen-Hsuan Ni, Hong-Yuan Hsu, Jane-Ling Wang, Mei-Hwei Chang, Predictive Effect of Serial Serum Alanine Aminotransferase Levels on Spontaneous HBeAg Seroconversion in Chronic Genotype B and C HBV–Infected Children, Journal of Pediatric Gastroenterology and Nutrition, 2012, 54, 1, 97

    CrossRef

  13. 13
    Makoto Arai, Seiko Togo, Tatsuo Kanda, Keiichi Fujiwara, Fumio Imazeki, Osamu Yokosuka, Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance, European Journal of Gastroenterology & Hepatology, 2012, 1

    CrossRef

  14. 14
    Jia-Feng Wu, Hong-Yuan Hsu, Yen-Hsuan Ni, Huey-Ling Chen, Tzee-Chung Wu, Mei-Hwei Chang, Suppression of Furin by Interferon-γ and the Impact on Hepatitis B Virus Antigen Biosynthesis in Human Hepatocytes, The American Journal of Pathology, 2012, 181, 1, 19

    CrossRef

  15. 15
    J.-F. Wu, C.-H. Chen, Y.-H. Ni, Y.-T. Lin, H.-L. Chen, H.-Y. Hsu, M.-H. Chang, Toll-like Receptor and Hepatitis B Virus Clearance in Chronic Infected Patients: A Long-Term Prospective Cohort Study in Taiwan, Journal of Infectious Diseases, 2012, 206, 5, 662

    CrossRef

  16. 16
    S. Togo, M. Arai, A. Tawada, T. Chiba, T. Kanda, K. Fujiwara, F. Imazeki, O. Yokosuka, Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B, Journal of Viral Hepatitis, 2011, 18, 10
  17. 17
    Ramazan Idilman, Mutlu Arat, Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation, Expert Review of Anti-infective Therapy, 2011, 9, 8, 641

    CrossRef

  18. 18
    Chien-Hung Chen, Chuan-Mo Lee, Chao-Hung Hung, Jing-Houng Wang, Tsung-Hui Hu, Chi-Sin Changchien, Sheng-Nan Lu, Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients, Journal of Gastroenterology and Hepatology, 2011, 26, 3
  19. 19
    Maximilian Lee, Emmet B. Keeffe, Hepatitis B: Modern End Points of Treatment and the Specter of Viral Resistance, Gastroenterology Clinics of North America, 2011, 40, 3, 495

    CrossRef

  20. 20
    Zhao Wang, Xiao-Ling Wu, Wei-Zheng Zeng, Hui Xu, Yong Zhang, Jian-Ping Qin, Ming-De Jiang, Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment, Virology Journal, 2011, 8, 1, 388

    CrossRef

  21. 21
    Yu-Ru Tseng, Jia-Feng Wu, Yen-Hsuan Ni, Huey-Ling Chen, Chih-Cheng Chen, Wan-Hsin Wen, Hong-Yuan Hsu, Mei-Hwei Chang, Long-term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection, Liver International, 2011, 31, 9
  22. 22
    Osamu Yokosuka, Masayuki Kurosaki, Fumio Imazeki, Yasuji Arase, Yasuhito Tanaka, Kazuaki Chayama, Eiji Tanaka, Hiromitsu Kumada, Namiki Izumi, Masashi Mizokami, Masatoshi Kudo, Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009, Hepatology Research, 2011, 41, 1
  23. 23
    Jia–Feng Wu, Wen–Yu Tsai, Hong–Yuan Hsu, Yen–Hsuan Ni, Huey–Ling Chen, Daw–Jen Tsuei, Mei–Hwei Chang, Effect of Puberty Onset on Spontaneous Hepatitis B Virus e Antigen Seroconversion in Men, Gastroenterology, 2010, 138, 3, 942

    CrossRef

  24. 24
    W. Chotiyaputta, A. S. F. Lok, Endpoints of hepatitis B treatment, Journal of Viral Hepatitis, 2010, 17, 10
  25. 25
    Masashi Mizokami, Eiji Tanaka, Kazuaki Chayama, Yasuhito Tanaka, Masayuki Kurosaki, Namiki Izumi, Yasuji Arase, Hiromitsu Kumada, Fumio Imazeki, Osamu Yokosuka, Masatoshi Kudo, JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis B, Kanzo, 2010, 51, 5, 243

    CrossRef

  26. 26
    Mitchell L. Shiffman, Management of Acute Hepatitis B, Clinics in Liver Disease, 2010, 14, 1, 75

    CrossRef

  27. 27
    Jurriën G.P. Reijnders, Moniek J. Perquin, Ningping Zhang, Bettina E. Hansen, Harry L.A. Janssen, Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients With Chronic Hepatitis B, Gastroenterology, 2010, 139, 2, 491

    CrossRef

  28. 28
    Jia–Feng Wu, Tzee–Chung Wu, Chien–Hung Chen, Yen–Hsuan Ni, Huey–Ling Chen, Hong–Yuan Hsu, Mei–Hwei Chang, Serum Levels of Interleukin-10 and Interleukin-12 Predict Early, Spontaneous Hepatitis B Virus e Antigen Seroconversion, Gastroenterology, 2010, 138, 1, 165

    CrossRef

  29. 29
    MARGARET JAMES KOZIEL, CHLOE LYNNE THIO, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  30. 30
    JULES L. DIENSTAG, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  31. 31
    Stefan Zeuzem, Edward Gane, Yun-Fan Liaw, Seng G. Lim, Adrian DiBisceglie, Maria Buti, Anuchit Chutaputti, Jens Rasenack, Jinlin Hou, Christopher O’Brien, Tuan T. Nguyen, Jidong Jia, Thierry Poynard, Bruce Belanger, Weibin Bao, Nikolai V. Naoumov, Baseline characteristics and early on-treatment response predict the outcomes of 2years of telbivudine treatment of chronic hepatitis B, Journal of Hepatology, 2009, 51, 1, 11

    CrossRef

  32. 32
    Hong You, Hong Ma, Tianhui Liu, Min Cong, Ping Wang, Xiaojuan Ou, Xiaoming Wang, Jiangbo Ren, Hongyi Li, Baoen Wang, Jidong Jia, Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles, Journal of Viral Hepatitis, 2009, 16, 12
  33. 33
    Iwona Mozer-Lisewska, Anna Mania, Wojciech Służewski, Paweł Kemnitz, Joanna Prusinowska, Arleta Kowala-Piaskowska, Magdalena Figlerowicz, Factors influencing clinical course and histological findings in children with chronic hepatitis B, European Journal of Gastroenterology & Hepatology, 2009, 21, 12, 1400

    CrossRef

  34. 34
    Raquel Viana, Renwei Wang, Mimi C. Yu, Robert Welschinger, Chien-Yu Chen, Michael C. Kew, Hepatitis B viral loads in southern African Blacks with hepatocellular carcinoma, Journal of Medical Virology, 2009, 81, 9
  35. 35
    Hyoung Su Kim, Ha Jung Kim, Woon Geon Shin, Kyung Ho Kim, Jin Heon Lee, Hak Yang Kim, Myoung Kuk Jang, Predictive Factors for Early HBeAg Seroconversion in Acute Exacerbation of Patients With HBeAg-Positive Chronic Hepatitis B, Gastroenterology, 2009, 136, 2, 505

    CrossRef

  36. 36
    L. Zhu, C. -H. Tse, V. W. -S. Wong, A. M. -L. Chim, K. -S. Leung, H. L. -Y. Chan, A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg-negative chronic hepatitis B in China, Journal of Viral Hepatitis, 2008, 15, 6
  37. 37
    Hui Ma, Lai Wei, Fang Guo, Sainan Zhu, Yan Sun, Hao Wang, Clinical features and survival in Chinese patients with hepatitis B e antigen-negative hepatitis B virus-related cirrhosis, Journal of Gastroenterology and Hepatology, 2008, 23, 8pt1
  38. 38
    Michael W. Fried, Teerha Piratvisuth, George K. K. Lau, Patrick Marcellin, Wan-Cheng Chow, Graham Cooksley, Kang-Xian Luo, Seung Woon Paik, Yun-Fan Liaw, Peter Button, Matei Popescu, HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B, Hepatology, 2008, 47, 2
  39. 39
    Jules L. Dienstag, Hepatitis B Virus Infection, New England Journal of Medicine, 2008, 359, 14, 1486

    CrossRef

  40. 40
    N. A. Singh, N. Reau, Management of hepatitis B virus, Journal of Antimicrobial Chemotherapy, 2008, 62, 2, 224

    CrossRef

  41. 41
    Karsten Wursthorn, Michael P. Manns, Heiner Wedemeyer, Natural history: The importance of viral load, liver damage and HCC, Best Practice & Research Clinical Gastroenterology, 2008, 22, 6, 1063

    CrossRef

  42. 42
    Teerha Piratvisuth, George Lau, You-Chen Chao, Rui Jin, Anuchit Chutaputti, Q.-B. Zhang, Tawesak Tanwandee, Peter Button, Matei Popescu, Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B, Hepatology International, 2008, 2, 1, 102

    CrossRef

  43. 43
    George V Papatheodoridis, Spilios Manolakopoulos, Geoffrey Dusheiko, Athanasios J Archimandritis, Therapeutic strategies in the management of patients with chronic hepatitis B virus infection, The Lancet Infectious Diseases, 2008, 8, 3, 167

    CrossRef

  44. 44
    Anna S. F. Lok, Brian J. McMahon, Chronic hepatitis B, Hepatology, 2007, 45, 2
  45. 45
    Kaveh Hoda, Mindie H. Nguyen, Chronic hepatitis B virus infection in patients with “Normal” ALT levels, Current Hepatitis Reports, 2007, 6, 1, 24

    CrossRef

  46. 46
    George Lau, Patrick Marcellin, Marion Peters, Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies, Hepatology International, 2007, 1, 2, 316

    CrossRef

  47. 47
    Hiroshi Yotsuyanagi, Kazuhiko Koike, Drug resistance in antiviral treatment for infections with hepatitis B and C viruses, Journal of Gastroenterology, 2007, 42, 5, 329

    CrossRef

  48. 48
    Chia-Chi Wang, Chun-Jen Liu, Ming-Yang Lai, Jia-Horng Kao, Ding-Shinn Chen, Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients, Liver International, 2007, 27, 2
  49. 49
    Ilan S. Weisberg, Robert S. Brown, Samuel H. Sigal, Hepatitis B and End-Stage Liver Disease, Clinics in Liver Disease, 2007, 11, 4, 893

    CrossRef

  50. 50
    Robert G. Gish, Improving outcomes for patients with chronic hepatitis B, Hepatology Research, 2007, 37,
  51. 51
    R. Iorio, A. Giannattasio, F. Cirillo, L. D'Alessandro, A. Vegnente, Long-Term Outcome in Children with Chronic Hepatitis B: A 24-Year Observation Period, Clinical Infectious Diseases, 2007, 45, 8, 943

    CrossRef

  52. 52
    Byung Kyu Park, Young Nyun Park, Sang Hoon Ahn, Kwan Sik Lee, Chae Yoon Chon, Young Myoung Moon, Chanil Park, Kwang-Hyub Han, Long-term outcome of chronic hepatitis B based on histological grade and stage, Journal of Gastroenterology and Hepatology, 2007, 22, 3
  53. 53
    N. Olivari, M. Pasino, S. Zanni, M. D’Onofrio, E. Martone, F. Donato, G. Fattovich, Natural course of hepatitis B e antigen positive chronic hepatitis B: Mortality after 25 years, Digestive and Liver Disease, 2007, 39, 3, A25

    CrossRef

  54. 54
    Emmet B. Keeffe, Stefan Zeuzem, Raymond S. Koff, Douglas T. Dieterich, Rafael Esteban–Mur, Edward J. Gane, Ira M. Jacobson, Seng G. Lim, Nikolai Naoumov, Patrick Marcellin, Teerha Piratvisuth, Fabien Zoulim, Report of an International Workshop: Roadmap for Management of Patients Receiving Oral Therapy for Chronic Hepatitis B, Clinical Gastroenterology and Hepatology, 2007, 5, 8, 890

    CrossRef

  55. 55
    XIII National Congress of Digestive Diseases, Italian Federation of Digestive Diseases – FIMAD Palermo, 29 September – 3 October 2007, Digestive and Liver Disease, 2007, 39, S139

    CrossRef

  56. 56
    Jia-Feng Wu, Chen-Hsin Chen, Rhong-Phong Hsieh, Hsiang-Hung Shih, Yi-Hau Chen, Chi-Rong Li, Chih-Yao Chiang, Wen-Yi Shau, Yen-Hsuan Ni, Huey-Ling Chen, Hong-Yuan Hsu, Mei-Hwei Chang, HLA typing associated with hepatitis B E antigen seroconversion in children with chronic hepatitis B virus infection: A long-term prospective sibling cohort study in Taiwan, The Journal of Pediatrics, 2006, 148, 5, 647

    CrossRef

  57. 57
    Kenji Ikeda, Yasuji Arase, Satoshi Saitoh, Masahiro Kobayashi, Takashi Someya, Tetsuya Hosaka, Hitomi Sezaki, Norio Akuta, Yoshiyuki Suzuki, Fumitaka Suzuki, Hiromitsu Kumada, Long-term Outcome of HBV Carriers with Negative HBe Antigen and Normal Aminotransferase, The American Journal of Medicine, 2006, 119, 11, 977

    CrossRef

  58. 58
    Steven-Huy B Han, Natural Course, Therapeutic Options and Economic Evaluation of Therapies for Chronic Hepatitis B, Drugs, 2006, 66, 14, 1831

    CrossRef

  59. 59
    Gang Chen, Wenyao Lin, Fumin Shen, Uchenna H. Iloeje, W. Thomas London, Alison A. Evans, Past HBV Viral Load as Predictor of Mortality and Morbidity from HCC and Chronic Liver Disease in a Prospective Study, The American Journal of Gastroenterology, 2006, 101, 8, 1797

    CrossRef

  60. 60
    M. SHERMAN, Personal view: the management of chronic hepatitis B infection, Alimentary Pharmacology & Therapeutics, 2006, 23, 7
  61. 61
    Hossein Bahrami, Nasser E. Daryani, Babak Haghpanah, Alireza Moayyeri, Katayoon Fayaz Moghadam, Shahram Mirmomen, Farin Kamangar, Effects of Indomethacin on Viral Replication Markers in Asymptomatic Carriers of Hepatitis B: A Randomized, Placebo-Controlled Trial, The American Journal of Gastroenterology, 2005, 100, 4, 856

    CrossRef

  62. 62
    M.-W. Yu, S.-H. Yeh, P.-J. Chen, Y.-F. Liaw, C.-L. Lin, C.-J. Liu, W.-L. Shih, J.-H. Kao, D.-S. Chen, C.-J. Chen, Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men, JNCI Journal of the National Cancer Institute, 2005, 97, 4, 265

    CrossRef

  63. 63
    Samuel H. Sigal, Aftab Ala, Katya Ivanov, Sabera Hossain, Carol Bodian, Thomas D. Schiano, Albert D. Min, Henry C. Bodenheimer, Swan N. Thung, Histopathology and clinical correlates of end-stage hepatitis B cirrhosis: A possible mechanism to explain the response to antiviral therapy, Liver Transplantation, 2005, 11, 1
  64. 64
    G.H. Zacharakis, J. Koskinas, S. Kotsiou, M. Papoutselis, F. Tzara, N. Vafeiadis, A.J. Archimandritis, K. Papoutselis, Natural history of chronic HBV infection: A cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project), Journal of Medical Virology, 2005, 77, 2
  65. 65
    George K.K. Lau, Teerha Piratvisuth, Kang Xian Luo, Patrick Marcellin, Satawat Thongsawat, Graham Cooksley, Edward Gane, Michael W. Fried, Wan Cheng Chow, Seung Woon Paik, Wen Yu Chang, Thomas Berg, Robert Flisiak, Philip McCloud, Nigel Pluck, Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B, New England Journal of Medicine, 2005, 352, 26, 2682

    CrossRef

  66. 66
    Jean-Pierre Villeneuve, The natural history of chronic hepatitis B virus infection, Journal of Clinical Virology, 2005, 34, S139

    CrossRef

  67. 67
    Emmet B. Keeffe, Douglas T. Dieterich, Steve-huy B. Han, Ira M. Jacobson, Paul Martin, Eugene R. Schiff, Hillel Tobias, Teresa L. Wright, A treatment algorithm for the management of chronic hepatitis B virus infection in the United States, Clinical Gastroenterology and Hepatology, 2004, 2, 2, 87

    CrossRef

  68. 68
    G. V. Papatheodoridis, S. J. Hadziyannis, Current management of chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2004, 19, 1
  69. 69
    Stephanos J Hadziyannis, George V Papatheodoridis, Emerging treatments in chronic hepatitis B, Expert Opinion on Emerging Drugs, 2004, 9, 2, 207

    CrossRef

  70. 70
    Baiqing Tang, Warren D. Kruger, Gang Chen, Fumin Shen, Wen Yao Lin, Souleymane Mboup, W. Thomas London, Alison A. Evans, Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers, Journal of Medical Virology, 2004, 72, 1
  71. 71
    KAZUYUKI OHATA, KEISUKE HAMASAKI, KAN TORIYAMA, HIROKI ISHIKAWA, KAZUHIKO NAKAO, KATSUMI EGUCHI, High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection, Journal of Gastroenterology and Hepatology, 2004, 19, 6
  72. 72
    Alfredo Alberti, Giovanna Fattovich, Natural history of chronic hepatitis B, Current Hepatitis Reports, 2004, 3, 2, 54

    CrossRef

  73. 73
    Chia-Ming Chu, Shao-Jen Hung, Justin Lin, Dar-In Tai, Yun-Fan Liaw, Natural history of hepatitis b e antigen to antibody seroconversion in patients with normal serum aminotransferase levels, The American Journal of Medicine, 2004, 116, 12, 829

    CrossRef

  74. 74
    Giovanna Fattovich, Natural history of hepatitis B, Journal of Hepatology, 2003, 39, 50

    CrossRef

  75. 75
    Mary Ann Huang, Anna S.F Lok, Natural history of hepatitis b and outcomes after liver transplantation, Clinics in Liver Disease, 2003, 7, 3, 521

    CrossRef

  76. 76
    Shoji Kubo, Kazuhiro Hirohashi, Osamu Yamazaki, Mitsuharu Matsuyama, Hiromu Tanaka, Katsuhiko Horii, Taichi Shuto, Takatsugu Yamamoto, Shuichi Kawai, Kenichi Wakasa, Shuhei Nishiguchi, Hiroaki Kinoshita, Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B, World Journal of Surgery, 2002, 26, 5, 555

    CrossRef

  77. 77
    Henry Lik-Yuen Chan, Steven Woon-Choi Tsang, May-Ling Wong, Chi-Hang Tse, Nancy Wai-Yee Leung, Francis Ka-Leung Chan, Joseph Jao-Yiu Sung, Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong, The American Journal of Gastroenterology, 2002, 97, 10, 2629

    CrossRef

  78. 78
    J. J.-Y. Sung, H. L.-Y. Chan, M. L. Wong, C.-H. Tse, S. C.-H. Yuen, J. S.-L. Tam, N. W.-Y. Leung, Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients, Journal of Viral Hepatitis, 2002, 9, 3
  79. 79
    Ewa Orlewska, The Cost-Effectiveness of Alternative Therapeutic Strategies for the Management of Chronic Hepatitis B in Poland, Value in Health, 2002, 5, 5, 405

    CrossRef

  80. 80
    G. V. Papatheodoridis, S. J. Hadziyannis, Diagnosis and management of pre-core mutant chronic hepatitis B, Journal of Viral Hepatitis, 2001, 8, 5
  81. 81
    R.A. Heijtink, H.L.A. Janssen, W.C.J. Hop, A.D.M.E. Osterhaus, S.W. Schalm, Interferon-alpha therapy for chronic hepatitis B: Early response related to pre-treatment changes in viral replication, Journal of Medical Virology, 2001, 63, 3
  82. 82
    Man-Fung Yuen, Ching-Lung Lai, Natural history of chronic hepatitis B virus infection, Journal of Gastroenterology and Hepatology, 2000, 15,
  83. 83
    Henry Lik-Yuen Chan, Yui Hui, Nancy Wai-Yee Leung, Jessica Yuet-Ling Ching, Francis Ka-Leung Chan, Joseph Jao-Yiu Sung, Risk factors for active liver disease in HBeAg-negative chronic hepatitis B virus-infected patients, The American Journal of Gastroenterology, 2000, 95, 12, 3547

    CrossRef

  84. 84
    Pierre Vandepapelière, Sexually Transmitted Diseases, 2000,

    CrossRef

  85. 85
    Giuseppe Mazzella, Giorgio Saracco, Davide Festi, Floriano Rosina, Sabrina Marchetto, Francesca Jaboli, Raffaello Sostegni, Alessandro Pezzoli, Francesco Azzaroli, Claudio Cancellieri, Marco Montagnani, Enrico Roda, Mario Rizzetto, Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial, The American Journal of Gastroenterology, 1999, 94, 8, 2246

    CrossRef

  86. 86
    Yasuji Arase, Kenji Ikeda, Naoya Murashima, Kazuaki Chayama, Akihito Tsubota, Isao Koida, Yoshiyuki Suzuki, Satoshi Saitoh, Masahiro Kobayashi, Mizuho Kobayashi, Mariko Kobayashi, Hiromitsu Kumada, Time course of histological changes in patients with a sustained biochemical and virological response to corticosteroid withdrawal therapy for chronic hepatitis B, The American Journal of Gastroenterology, 1999, 94, 11, 3304

    CrossRef

  87. 87
    Giovanna Fattovich, Maria Lisa Ribero, Susanna Favarato, Franco Azzario, Francesco Donato, Giuliano Giustina, Michele Fasola, Maurizio Pantalena, Giuseppe Portera, Alessandro Tagger, Influence of GB virus-C/hepatitis G virus infection on the long-term course of chronic hepatitis B, Liver, 1998, 18, 5
  88. 88
    F ter Borg, FJW ten Kate, HTM Cuypers, A Leentvaar-Kuijpers, J Oosting, PME Wertheim-van Dillen, P Honkoop, MC Rasch, RA de Man, J van Hattum, RAFM Chamuleau, HW Reesink, EA Jones, Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen, The Lancet, 1998, 351, 9120, 1914

    CrossRef

  89. 89
    Richard L Hodinka, The clinical utility of viral quantitation using molecular methods, Clinical and Diagnostic Virology, 1998, 10, 1, 25

    CrossRef

  90. 90
    Elizabeth H. Boxall, Sarah Peterson, J. Diment, Susan E. Graham, Jane A. Shirley, A novel assay for hepatitis B e markers, Journal of Medical Virology, 1997, 52, 3
  91. 91
    Pieter Honkoop, Robert A. Man, Pieter E. Zondervan, Solko W. Schalm, Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine, Liver, 1997, 17, 2
  92. 92
    Yasuji Arase, Kazuaki Chayama, Akihito Tsubota, Naoya Murashima, Yoshiyuki Suzuki, Isao Koida, Masahiro Kobayashi, Satoshi Saitoh, Kenji Ikeda, Hiromitsu Kumada, Mariko Kobayashi, Hiroshi Suzuki, A randomized, double-blind, controlled trial of natural interferon-β therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels, Journal of Gastroenterology, 1996, 31, 4, 559

    CrossRef

  93. 93
    Claus Niederau, Tobias Heintges, Stefan Lange, Georg Goldmann, Christoph M. Niederau, Leonhard Mohr, Dieter Häussinger, Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B, New England Journal of Medicine, 1996, 334, 22, 1422

    CrossRef

  94. 94
    George Marinos, Francesco Torre, Shilpa Chokshi, Munther Hussain, Berwin E. Clarke, David J. Rowlands, Adrian L. W. F. Eddleston, Nikolai V. Naoumov, Roger Williams, Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: A major factor in activation of the host immune response to the hepatitis B virus, Hepatology, 1995, 22, 4
  95. 95
    R. A. Heijtink, J. Snobl, J. Kruining, C. Kerkhof-Los, R. A. de Man, H. L. A. Janssen, S. W. Schalm, Quantitative measurement of HBeAg in chronic hepatitis B: A comparison between a radioimmunoassay a fluorescence ELISA and a chemiluminescence ELISA, Journal of Medical Virology, 1995, 47, 3
  96. 96
    Mei-Hwei Chang, Hong-Yuan Hsu, Hey-Chi Hsu, Yen-Hsuan Ni, Juei-San Chen, Ding-Shinn Chen, The significance of spontaneous hepatitis B e antigen seroconversion in childhood: With special emphasis on the clearance of hepatitis B e antigen before 3 years of age, Hepatology, 1995, 22, 5
  97. 97
    Giovanna Fattovich, Giuliano Giustina, Alfredo Alberti, Maria Guido, Patrizia Pontisso, Susanna Favarato, Luisa Benvegnù, Arturo Ruol, A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B, Journal of Hepatology, 1994, 21, 3, 361

    CrossRef

  98. 98
    H. Higashi, T. Matsumata, E. Adachi, A. Taketomi, S. Kashiwagi, K. Sugimachi, Influence of viral hepatitis status on operative morbidity and mortality in patients with primary hepatocellular carcinoma, British Journal of Surgery, 1994, 81, 9
  99. 99
    G. Zöhrens, T. Armbrust, K. -H. Meyer Zum Büschenfelde, G. Ramadori, Interferon-α2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection, Digestive Diseases and Sciences, 1994, 39, 9, 2007

    CrossRef

  100. 100
    Harry L.A. Janssen, Coby J. Kerhof-Los, Rudolf A. Heijtink, Solko W. Schalm, Measurement of HBsAg to monitor hepatitis B viral replication in patients on α-interferon therapy, Antiviral Research, 1994, 23, 3-4, 251

    CrossRef

  101. 101
    David K.H. Wong, Jenny Heathcote, The role of interferon in the treatment of viral hepatitis, Pharmacology & Therapeutics, 1994, 63, 2, 177

    CrossRef

  102. 102
    Patrizia Pontisso, Maria Grazia Ruvoletto, Giovanna Fattovich, Liliana Chemello, Alberto Gallorini, Arturo Ruol, Alfredo Alberti, Clinical and virological profiles in patients with multiple hepatitis virus infections, Gastroenterology, 1993, 105, 5, 1529

    CrossRef

  103. 103
    Fabio Tinè, Alessandro Liberati, Antonio Craxì, Piero Almasio, Luigi Pagliaro, Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature, Journal of Hepatology, 1993, 18, 2, 154

    CrossRef

  104. 104
    AKIHIKO KIMURA, MAKADO MATSUYUKI, KEN YUGE, EIICHIRO ONO, NORIKAZU KURIYA, HIROHISA KATO, Natural history of Japanese children with chronic hepatitis B: Seroconversion from HBeAg to anti-HBe, Pediatrics International, 1993, 35, 6
  105. 105
    Harry L.A. Janssen, Solko W. Schalm, Lucas Berk, de Man Robert A., Rudolf A. Heijtink, Repeated courses of α-interferon for treatment of chronic hepatitis type B, Journal of Hepatology, 1993, 17, S47

    CrossRef

  106. 106
    Giovanna Fattovich, Patrizia Farci, Massimo Rugge, Lucio Brollo, Antonella Mandas, Patrizia Pontisso, Giuliano Giustina, M. Eliana Lai, Fabio Belussi, Graziella Busatto, Angelo Balestrieri, Arturo Ruol, Alfredo Alberti, A randomized controlled trial of lymphoblastoid interferon-α in patients with chronic hepatitis B lacking HBeAg, Hepatology, 1992, 15, 4
  107. 107
    S. Gayno, P. Marcellin, M.A. Loriot, M. Martinot-Peignoux, P. Levy, S. Erlinger, J.P. Benhamou, Detection of serum HBV-DNA by polymerase chain reaction (PCR) in patients before reactivation of chronic hepatitis B, Journal of Hepatology, 1992, 14, 2-3, 357

    CrossRef

  108. 108
    Andrew Shead, Karen Vickery, Aniko Pajkos, Robert Medhurst, John Freiman, Robert Dixon, Yvonne Cossart, Effects of Phyllanthus plant extracts on duck hepatitis B virus in vitro and in vivo, Antiviral Research, 1992, 18, 2, 127

    CrossRef

  109. 109
    Lucas Berk, Solko W. Schalm, Robert A. de Man, Rudolf A. Heytink, Pierre Berthelot, Christian Brechot, Bernard Boboc, Françoise Degos, Patrick Marcellin, Jean-Pierre Benhamou, Georg Hess, Siegbert Rossol, Karl-Hermann Meyer zum Büschenfelde, Robert A.F.M. Chamuleau, Peter L.M. Jansen, Henk W. Reesink, Beat Meyer, Christoph Beglinger, Georg A. Stalder, Jannie W. den Ouden-Muller, Maurits de Jong, Failure of acyclovir to enhance the antiviral effect of α lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B, Journal of Hepatology, 1992, 14, 2-3, 305

    CrossRef

  110. 110
    Patrick Marcellin, Jean-François Colin, Nathalie Boyer, Jacques Bernuau, Claude Degott, Claire Hirschauer, Jean-Pierre Benhamou, Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon, The Lancet, 1991, 338, 8770, 828

    CrossRef

  111. 111
    Gary L. Davis, Loss of HBsAg after interferon-α treatment: Cure of chronic hepatitis B virus?, Hepatology, 1991, 14, 5
  112. 112
    Hiroshi Sakugawa, Tomohisa Ohwan, Akihiro Yamashiro, Tominori Oyakawa, Keizo Kadena, Fukunori Kinjo, Atsushi Saito, Natural seroconversion from hepatitis be antigen to antibody among hepatitis B virus carriers in Okinawa islands, Journal of Medical Virology, 1991, 34, 2
  113. 113
    Pierre Brissot, Christian Jacquelinet, Hervé Jouanolle, Véronique David, Dominique Guyader, Monique Guéguen, Martine Blayau, Gérard Lescoat, Michel Messner, Yves Deugnier, Short-term prednisolone followed by recombinant human α-interferon alone or combined with adenine-arabinoside in chronic hepatitis B, Journal of Hepatology, 1991, 12, 2, 181

    CrossRef

  114. 114
    Cho-Yu Chan, Shou-Dong Lee, Jaw-Ching Wu, Shinn-Jang Hwang, Yan-Jenn Wang, Yi-Shin Huang, Kwang-Juei Lo, Superinfection with hepatitis C virus in patients with symptomatic chronic hepatitis B, Scandinavian Journal of Infectious Diseases, 1991, 23, 4, 421

    CrossRef

  115. 115
    H.C. Thomas, P. Karayiannis, G. Brook, Treatment of hepatitis B virus infection with interferon, Journal of Hepatology, 1991, 13, S4

    CrossRef

  116. 116
    Shuping Tong, Jisu Li, Ludiviila Vitvitski, Christian Trépo, Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region, Virology, 1990, 176, 2, 596

    CrossRef

  117. 117
    Giovanna Fattovich, Lucio Brollo, Alfrede Alberti, Giuliano Giustina, Patrizia Pontisso, Giuseppe Realdi, Arturo Ruol, Chronic persistent hepatitis type B can be a progressive disease when associated with sustained virus replication, Journal of Hepatology, 1990, 11, 1, 29

    CrossRef

  118. 118
    Philippe Levy, Patrick Marcellin, Michèle Martinot-Peignoux, Claude Degott, Joëlle Nataf, Jean-Pierre Benhamou, Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B, Hepatology, 1990, 12, 3
  119. 119
    J. Fevery, A. Elewaut, P. Michielsen, F. Nevens, P. Van Eyken, M. Adler, V. Desmet, Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study, Journal of Hepatology, 1990, 11, S108

    CrossRef

  120. 120
    M. Rapicetta, V. Di Nardo, C. Rozera, G. Marinucci, D. Francisci, B. Sarrecchia, C. Ricci, F. Albertoni, HBV-DNA, HBeAg/anti-HBe serological status in hepatitis B chronic individuals from central Italy, Epidemiology and Infection, 1990, 104, 03, 511

    CrossRef

  121. 121
    S. Sherlock, Hepatitis B: the disease, Vaccine, 1990, 8, S6

    CrossRef

  122. 122
    Kim Krogsgaard, Jan Aldershvile, Peter Kryger, Court Pedersen, Poul Andersson, Henrik Dalbøge, Jens Ole Nielsen, Bengt Göran Hansson, Reactivation of viral replication in anti-HBe positive chronic HBsAg carriers, Liver, 1990, 10, 1
  123. 123
    Giovanna Fattovich, Lucio Brollo, Alfredo Alberti, Giuseppe Realdi, Patrizia Pontisso, Giuliano Giustina, Arturo Ruol, Spontaneous reactivation of hepatitis B virus infection in patients with chronic type B hepatitis, Liver, 1990, 10, 3
  124. 124
    Mei-Hwei Chang, Juei-Low Sung, Chin-Yun Lee, Chien-Jen Chen, Juei-San Chen, Hong-Yuan Hsu, Ping-Ing Lee, Ding-Shinn Chen, Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children, The Journal of Pediatrics, 1989, 115, 3, 385

    CrossRef

  125. 125
    P. Pontisso, F. Bortolotti, G. Fattovich, M.G. Ruvoletto, G. Realdi, A. Alberti, Hepatitis B virus DNA forms in the liver of chronically infected individuals, Journal of Hepatology, 1989, 9, 1, 29

    CrossRef

  126. 126
    M.Gary Brook, Lidija Petrovic, Jenny A. McDonald, Peter J. Scheuer, Howard C. Thomas, Histological improvement after anti-viral treatment for chronic hepatitis B virus infection, Journal of Hepatology, 1989, 8, 2, 218

    CrossRef

  127. 127
    Giovanna Fattovich, Lucio Brollo, Stefania Boscaro, Patrizia Pontisso, Giuliano Giustina, Domenico Criscuolo, Dionigi Maladorno, Alfredo Alberti, Giuseppe Realdi, Arturo Ruol, Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B, Journal of Hepatology, 1989, 9, 3, 331

    CrossRef

  128. 128
    HSIEN-HONG LIN, YUN-FAN LIAW, TONG-JONG CHEN, CHIA-MING CHU, MIAU-JU HUANG, Natural course of patients with chronic type B hepatitis following acute hepatitis delta virus superinfection, Liver, 1989, 9, 3
  129. 129
    Stephen J. Williams, Geoffrey C. Farrell, Serial antipyrine clearance studies detect altered hepatic metabolic function during spontaneous and interferon-induced changes in chronic hepatitis B disease activity, Hepatology, 1989, 10, 2
  130. 130
    M. Gary Brook, Peter Karayiannis, Howard C. Thomas, Which patients with chronic hepatitis B virus infection will respond to α-interferon therapy? A statistical analysis of predictive factors, Hepatology, 1989, 10, 5
  131. 131
    José M. Sánchez-Tapias, Josep Costa, Antoni Mas, Albert Parés, Miguel Bruguera, Joan Rodés, Analysis of factors predicting early seroconversion to anti-HBe in HBeAg-positive chronic hepatitis B, Journal of Hepatology, 1988, 6, 1, 15

    CrossRef

  132. 132
    M. G. Courtney, D. G. Weir, G. S. A. McDonald, Alain G. Lachaux, Bruno P. Descos, Irene C. Loras-Duclaux, Michel R. Hermier, G. Fattovich, A. Alberti, G. Realdi, G. Hoffman, Elsewhere correspondence, Hepatology, 1988, 8, 1
  133. 133
    Giovanni Raimondo, Robert D. Burk, Harvey M. Lieberman, Joseph Muschel, Stephanos J. Hadziyannis, Hans Will, Michael C. Kew, Geoffrey M. Dusheiko, David A. Shafritz, Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma, Virology, 1988, 166, 1, 103

    CrossRef

  134. 134
    Giovanna Fattovich, Lucio Brollo, Alfredo Alberti, Patrizia Pontisso, Giuliano Giustina, Giuseppe Realdi, Long-term follow-up of anti-HBe-positive chronic active hepatitis B, Hepatology, 1988, 8, 6
  135. 135
    J. Jové, J. M. Sánchez-Tapias, M. Bruguera, A. Mas, J. Costa, J. M. Barrera, J. Rodés, Post-transfusional vs. sporadic non-A, non-B chronic hepatitis. A clinico-pathological and evolutive study, Liver, 1988, 8, 1
  136. 136
    Jaw-Ching Wu, Shou-Dong Lee, Shyh-Haw Tsay, Yang-Te Tsai, Cho-Yu Chan, Yi-Shin Huang, Kwang-Juei Lo, Ling-Pai Ting, Symptomatic anti-HBe positive chronic hepatitis B in taiwan with special reference to persistent HBV replication and HDV superinfection, Journal of Medical Virology, 1988, 25, 2
  137. 137
    Gudrun Lindh, Ola Weiland, Hans Glaumann, The application of a numerical scoring system for evaluating the histological outcome in patients with chronic hepatitis B followed in long term, Hepatology, 1988, 8, 1
  138. 138
    Hey-Chi Hsu, Ih-Jen Su, Ming-Yang Lai, Ding-Shinn Chen, Mei-Hwei Chang, Sou-Ming Chuang, Juei-Low Sung, Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection, Journal of Hepatology, 1987, 5, 1, 45

    CrossRef

  139. 139
    DING-SHINN CHEN, JUEI-LOW SUNG, Hepatitis B e antigen and its antibody in chronic type B hepatitis, Journal of Gastroenterology and Hepatology, 1987, 2, 3
  140. 140
    L.J. Scully, R. Shein, P. Karayiannis, J.A. McDonald, H.C. Thomas, Lymphoblastoid interferon therapy of chronic HBV infection, Journal of Hepatology, 1987, 5, 1, 51

    CrossRef

  141. 141
    D. Larzul, V. Thiers, A.M. Courouce, C. Bréchot, J.-L. Guesdon, Non-radioactive hepatitis B virus DNA probe for detection of HBV-DNA in serum, Journal of Hepatology, 1987, 5, 2, 199

    CrossRef